Skip to main content
logo
Adaptive Biotechnologies Corporation (MUN:1HM)
Germany flag Germany · Delayed Price · Currency is EUR
13.18
0.00 (0.00%)
Last updated: Dec 16, 2025, 8:00 AM CET

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Minimal Residual Disease - Service
133.03M
Log In
Log In
Log In
Log In
Upgrade
Minimal Residual Disease - Service Growth
29.48%
Log In
Log In
Log In
Log In
Upgrade
Immune Medicine - Service
19.98M
Log In
Log In
Log In
Log In
Upgrade
Immune Medicine - Service Growth
-19.96%
Log In
Log In
Log In
Log In
Upgrade
Immune Medicine - Collaboration
13.45M
Log In
Log In
Log In
Log In
Upgrade
Immune Medicine - Collaboration Growth
-68.41%
Log In
Log In
Log In
Log In
Upgrade
Minimal Residual Disease - Regulatory Milestone
12.50M
Log In
Log In
Log In
Log In
Upgrade
Sequencing
-
Log In
Log In
Log In
Log In
Upgrade
Sequencing Growth
-
Log In
Log In
Log In
Log In
Upgrade
Development Support
-
Log In
Log In
Log In
Log In
Upgrade
Development Support Growth
-
Log In
Log In
Log In
Log In
Upgrade
Regulatory Milestones
-
Log In
Log In
Log In
Log In
Upgrade
Regulatory Milestones Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
United States
178.96M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
5.10%
Log In
Log In
Log In
Log In
Upgrade